Generics and Biosimilars

Our Sandoz Division is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines. Sandoz is the only generics company with a top 3 position in all major regions of the world, reaching more than 500 million patients annually and playing a leading role in generating savings for healthcare systems worldwide.

We offer approximately 1,000 molecules covering a broad range of therapeutic areas and are a recognized leader in Antibiotics with over 150 different product and technology combinations.

We have a very high LoE coverage and are on track to submit 40 ‘first to files’ in the US by 2024.

We would be excited to discuss partnerships that allow us to strengthen our footprint in differentiated and/or promotable generics. We would consider all requests, in a therapeutic area agnostic manner, but would be especially interested in opportunities in the anti-infectives and respiratory segments.


Silhouette of a man

Small Molecules

Contact us for partnerships after clinical PoC

We are Number one biosimilar company in the world, with 8 marketed molecules and a strong portfolio of 15+ assets.

Our aspiration is to continue to help millions of patients to access affordable, sustainable biologics through internally developed as well as externally partnered medicines and retain our leadership in the area.

Please contact one of the following partnering professionals; we look forward to the chance of working with you.


Ulrich Oswald

Ulrich Osswald

Contact

 


Helga Grupe

Helga Grupe

Contact

 


Silhouette of a man

Christophe Price

Contact